Status not kept up to date
Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic Neoplasms
NCT05259384 · Peking Union Medical College Hospital · Updated 28 Feb 2022
- What is being tested
- Robotic pancreaticoduodenectomy; Laparoscopic pancreaticoduodenectomy; Robotic Distal Pancreatectomy; Laparoscopic Distal Pancreatectomy
- For
- Pancreatic Neoplasm
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 120 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 17 April 2021, ends 31 Oct 2024. Registered 28 Feb 2022.
- Results
- None posted yet.
In the researchers' words
Pancreatic cystic neoplasm (PCN) is a type of neoplastic lesion formed by the proliferation of pancreatic duct or acinar epithelial cells and retention of pancreatic secretions. The tumor can be located in the head and neck of the pancreas or the body and tail of the pancreas. Conventionally, open pancreaticoduodenectomy or open distal pancreatectomy was performed for patients with PCN locates either at the head or tail. In the ear of minimally invasive pancreatic surgery, when compared with open surgery, laparoscopic technology or Da Vinci robotic technology can avoid some open procedures limitations. Here we design this prospective randomized clinical trial to compare robotic surgery to laparoscopic surgery for the treatment of PCN and verify the safety and feasibility of both two minimally invasive procedures.
Sites
- Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaBeijing, China
